Companion Notes
Each note pairs with a chapter of Global Health Research in Practice and takes one idea further, using a real study and code and data you can run yourself.
Chapter 6: Statistical Inference
Chapter 7: Causal Inference
Chapter 9: Measurement
Chapter 10: Experimental Designs
Testing Ebola Drugs in an Epidemic
How a decade of Ebola research produced licensed treatments — and what happens next
Testing Ebola Vaccines in an Epidemic
How the same crisis produced two licensed vaccines — by two very different standards of evidence
When Should a Trial Stop?
Bayesian Adaptive Design in a Kenyan Eye Care Program
Can You Blind a Psychedelic?
Functional Unblinding, Expectancy Bias, and What It Means for Psychedelic Trial Design
What Does 'Clinically Meaningful' Mean?
MADRS Thresholds, MCID, and the Difference Between Statistical and Clinical Significance
What Counts as a 'Clinical Trial'?
How the NIH's Shifting Definition Reshapes Transparency in Research
What Makes a Trial 'Adequate and Well-Controlled'?
Lessons from the FDA's Refusal to Review an mRNA Flu Vaccine
Chapter 11: Quasi-Experimental Designs
Chapter 14: Other Designs
Chapter 21: Publishing
More on the Way
New companion notes are added as chapters are released. Have a topic you'd like to see covered? Let us know.
Suggest a Topic